Natco Pharma has acquired 4 crore shares of the biotech firm E-Genesis, which specializes in the safe transportation of body parts. Headquartered in Hyderabad, Natco Pharma expressed enthusiasm about this investment in E-Genesis, which is based in Canada. E-Genesis’s advanced techniques are particularly beneficial for kidney, liver, and heart surgeries. The company has recently gained recognition for setting a world record in 2024 by successfully transplanting a pig’s kidney into a human. This groundbreaking procedure has received approval and certification from the U.S. Food and Drug Administration (FDA). E-Genesis has welcomed Natco Pharma’s investment with great appreciation.